AbbVie submitted FDA and EMA applications seeking approval of upadacitinib (RINVOQ) 15 mg once daily for adults and adolescents aged 12 years and older with non-segmental vitiligo. Phase 3 Viti-Up ...
A look back at the FDA submissions and regulatory decisions in the pediatric health care space from January 2026. Another month has come and gone, and with it, several FDA approvals and regulatory ...
New AAP guidance affirms mother’s own milk as optimal for very low birth weight infants, citing reduced NEC and infection risk and outlining donor milk use. A mother’s own milk provides the strongest ...
FDA clears first at-home test to detect RSV, influenza, and COVID-19 in infants as young as 6 months
FDA-cleared Flowflex Plus 4-in-1 home test detects RSV, influenza A/B, and COVID-19 in adults and children as young as 6 months. ACON Laboratories, Inc, announced the retail availability of the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results